quinacrine has been researched along with Hermanski-Pudlak Syndrome in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Hermanski-Pudlak Syndrome: Syndrome characterized by the triad of oculocutaneous albinism (ALBINISM, OCULOCUTANEOUS); PLATELET STORAGE POOL DEFICIENCY; and lysosomal accumulation of ceroid lipofuscin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, O | 1 |
| Wiegering, V | 1 |
| König, EM | 1 |
| Schneider, AL | 1 |
| Semeniak, D | 1 |
| Stritt, S | 1 |
| Klopocki, E | 1 |
| Schulze, H | 1 |
| Billio, A | 1 |
| Moeseneder, C | 1 |
| Donazzan, G | 1 |
| Triani, A | 1 |
| Pescosta, N | 1 |
| Coser, P | 1 |
2 other studies available for quinacrine and Hermanski-Pudlak Syndrome
| Article | Year |
|---|---|
A novel two-nucleotide deletion in HPS6 affects mepacrine uptake and platelet dense granule secretion in a family with Hermansky-Pudlak syndrome.
Topics: Adenosine Triphosphate; Adolescent; Antineoplastic Agents; Base Sequence; Biological Transport; Bloo | 2017 |
Hermansky-Pudlak syndrome: clinical presentation and confirmation of the value of the mepacrine-based cytofluorimetry test in the diagnosis of delta granule deficiency.
Topics: Blood Platelets; Family Health; Female; Flow Cytometry; Hermanski-Pudlak Syndrome; Humans; Male; Mid | 2001 |